pN0肺腺癌R0肺叶切除术后远处复发的相关因素
回顾性分析893例pT1-3N0M0肺腺癌行R0肺叶切除术患者,中位随访35.0个月。5年远处复发累积发生率为14%(95%CI 11%-17%)。pT2a(HR 2.84)、pT2b/3(HR 6.53)和淋巴血管侵犯(HR 1.62)与远处复发相关,近期手术与远处复发减少相关(HR 0.43)。
要点
- pT2a(HR 2.84)和pT2b/3(HR 6.53)与远处复发相关。
- 淋巴血管侵犯与远处复发相关(HR 1.62;P = .05)。
- 无病生存独立关联pT分期(P < .001)和淋巴血管侵犯(P = .004)。
核心结论
- 在行R0肺叶切除术的pN0肺腺癌患者中,pT分期和淋巴血管侵犯与远处复发及无病生存降低相关。
- 这些观察支持将此类患者纳入未来探究辅助靶向治疗和免疫治疗的临床试验。
研究设计与样本
- 对前瞻性维护的pT1-3N0M0非小细胞肺癌数据库进行回顾性分析。
- 排除异时性肺癌、亚肺叶/不完全切除、非腺癌组织学及诱导/辅助治疗。
- 共识别2392例pT1-3N0M0肺腺癌患者,其中893例符合纳入标准。
- 主要结局为远处复发,次要结局为无病生存和总生存。
- 采用Fine-Gray竞争风险回归分析远处复发,Cox比例风险模型分析无病生存和总生存。
主要发现
- 中位随访35.0个月(范围0.1-202个月)。
- 13%的患者出现复发(n = 115),其中86%(n = 99)为远处复发。
- 5年远处复发累积发生率为14%(95%CI 11%-17%)。
- 多变量分析中,pT2a(HR 2.84;95%CI 1.56-5.16;P = .001)和pT2b/3(HR 6.53;95%CI 3.17-13.5;P < .001)肿瘤与远处复发相关。
- 近期手术与远处复发减少相关(HR 0.43;95%CI 0.20-0.91;P = .028),淋巴血管侵犯与远处复发强相关(HR 1.62;95%CI 1.00-2.63;P = .05)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We investigated factors associated with distant recurrence, disease-free survival (DFS), and overall survival (OS) following R0 lobectomy for pathologic node-negative (pN0) lung adenocarcinoma. METHODS: We performed a retrospective analysis of a prospectively maintained database of patients with pT1-3N0M0 non-small cell lung cancer. Exclusion criteria included metachronous lung cancer, sublobar/incomplete resection, nonadenocarcinoma histology, and induction/adjuvant therapy. The primary outcome was distant recurrence; secondary outcomes were DFS and OS. Associations between variables and outcomes were assessed by Fine-Gray competing-risk regression for distant recurrence and Cox proportional hazard models for DFS and OS. RESULTS: Of 2392 patients identified with pT1-3N0M0 lung adenocarcinoma, 893 met the inclusion criteria. Median follow-up was 35.0 months (range, 0.1-202 months). Thirteen percent of patients developed recurrence (n = 115), of which 86% (n = 99) were distant. The 5-year cumulative incidence of distant recurrence was 14% (95% confidence interval [CI], 11%-17%). On multivariable analysis, pT2a (hazard ratio [HR], 2.84; 95% CI, 1.56-5.16; P = .001) and pT2b/3 (HR, 6.53; 95% CI, 3.17-13.5; P < .001) tumors were associated with distant recurrence. Recent surgery was associated with decreased distant recurrence (HR, 0.43; 95% CI, 0.20-0.91; P = .028), and lymphovascular invasion was strongly associated with distant recurrence (HR, 1.62; 95% CI, 1.00-2.63; P = .05). DFS was independently associated with pT stage (P < .001) and lymphovascular invasion (P = .004). CONCLUSIONS: In patients undergoing R0 lobectomy with pN0 lung adenocarcinoma, pT stage and lymphovascular invasion were associated with distant recurrence and decreased DFS. These observations support the inclusion of these patients in future clinical trials investigating adjuvant targeted and immunotherapies.
引用
- Brandt WS, Bouabdallah I, Tan KS, et al. Factors associated with distant recurrence following R0 lobectomy for pN0 lung adenocarcinoma. J Thorac Cardiovasc Surg. 2017. PMID: 29246549. doi:10.1016/j.jtcvs.2017.09.151
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。